7 insiders reported 110 Form 4 transactions for Apogee Therapeutics, Inc. (APGE) over the past 18 months (most recent 2026-07-02). Recent activity: Dambkowski Carl (Chief Medical Officer) Buy 4,125 shares, Dambkowski Carl (Chief Medical Officer) Sell 5,500 shares, HENDERSON MICHAEL THOMAS (Chief Executive Officer) Sell 80,000 shares, Dambkowski Carl (Chief Medical Officer) Sell 26,400 shares, HENDERSON MICHAEL THOMAS (Chief Executive Officer) Sell 6,770 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-07-02 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $730,070 |
| 2026-06-24 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 80,000 | $10.6M |
| 2026-06-24 | Dambkowski Carl | Chief Medical Officer | Sell | 26,400 | $3.5M |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 6,770 | $556,562 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 7,654 | $633,598 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 1,080 | $90,914 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 1,577 | $134,345 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 2,305 | $198,852 |
| 2026-06-12 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 614 | $53,350 |
| 2026-06-05 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-06-05 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $432,905 |
| 2026-05-15 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 18,659 | $1.5M |
| 2026-05-15 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 1,341 | $110,740 |
| 2026-05-08 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-05-08 | Dambkowski Carl | Chief Medical Officer | Sell | 3,700 | $310,504 |
| 2026-05-08 | Dambkowski Carl | Chief Medical Officer | Sell | 1,800 | $152,280 |
| 2026-04-20 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Buy | 3,000 | $68,580 |
| 2026-04-17 | Henderson Jane | Chief Financial Officer | Sell | 2,000 | $180,000 |
| 2026-04-10 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 17,800 | $1.5M |
| 2026-04-10 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 2,000 | $166,520 |
| 2026-04-10 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 200 | $17,000 |
| 2026-04-03 | Dambkowski Carl | Chief Medical Officer | Buy | 4,125 | $94,298 |
| 2026-04-03 | Henderson Jane | Chief Financial Officer | Sell | 900 | $76,014 |
| 2026-04-03 | Henderson Jane | Chief Financial Officer | Sell | 1,100 | $94,006 |
Source: SEC Form 4 filings · as of 2026-07-02